(S1 (S (NP (NP (NN Down-regulation)) (PP (IN of) (NP (NP (NN interferon) (JJ regulatory) (NN factor) (CD 4)) (NN gene) (NN expression))) (PP (IN in) (NP (JJ leukemic) (NNS cells))) (PP (IN due) (TO to) (NP (NP (NN hypermethylation)) (PP (IN of) (NP (NN CpG) (NNS motifs))) (PP (IN in) (NP (DT the) (NN promoter) (NN region))))))))
(S1 (S (S (SBAR (IN Although) (S (NP (DT the) (NN bcr-abl) (NN translocation)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (JJ causative) (JJ genetic) (NN aberration)) (PP (IN in) (NP (NP (JJ chronic) (JJ myeloid) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN CML)) (-RRB- -RRB-))))))))))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (JJ mounting) (NN evidence) (SBAR (IN that) (S (NP (NP (DT the) (NN deregulation)) (PP (IN of) (NP (NP (JJ other) (NNS genes)) (, ,) (PP (JJ such) (IN as) (NP (NP (DT the) (NN transcription) (NN factor) (NN interferon) (JJ regulatory) (NN factor) (CD 4)) (PRN (-LRB- -LRB-) (NP (NN IRF-4)) (-RRB- -RRB-)))) (, ,)))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NN CML)))))))))))) (. .)))
(S1 (S (S (NP (NP (NP (NN Promoter) (NN methylation)) (PP (IN of) (NP (NN CpG) (NN target) (NNS sites)))) (CC or) (NP (NP (JJ direct) (NNS deletions/insertions)) (PP (IN of) (NP (NNS genes))))) (VP (VBP are) (NP (NP (NNS mechanisms)) (PP (IN of) (NP (NP (DT a) (ADJP (ADJP (JJ reversible)) (CC or) (ADJP (JJ permanent))) (NN silencing)) (PP (IN of) (NP (NN gene) (NN expression)))))) (, ,) (ADVP (RB respectively)))) (. .)))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBD investigated) (SBAR (IN whether) (S (NP (NP (NN IRF-4) (NN promoter) (NN methylation)) (CC or) (NP (NN mutation))) (VP (MD may) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN IRF-4) (NN expression)) (PP (IN in) (NP (NN leukemia) (NNS cells)))))))))))))) (. .)))
(S1 (S (S (SBAR (IN Whereas) (S (NP (NP (NN promoter) (NNS mutations)) (CC or) (NP (JJ structural) (NNS rearrangements))) (VP (MD could) (VP (VB be) (VP (VBN excluded) (PP (IN as) (NP (NP (DT a) (NN cause)) (PP (IN of) (NP (NP (JJ altered) (NN IRF-4) (NN expression)) (PP (IN in) (NP (JJ hematopoietic) (NNS cells)))))))))))) (, ,) (NP (DT the) (NN IRF-4) (NN promoter) (NN methylation) (NN status)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (ADVP (RB significantly)) (VP (VB influence) (NP (NN IRF-4) (NN transcription)))))))) (. .)))
(S1 (S (S (ADVP (RB First)) (, ,) (NP (NP (NN treatment)) (PP (IN of) (NP (JJ IRF-4-negative) (ADJP (ADJP (JJ lymphoid)) (, ,) (ADJP (JJ myeloid)) (CC and) (ADJP (JJ monocytic))) (NN cell) (NNS lines))) (PP (IN with) (NP (DT the) (JJ methylation-inhibitor) (NN 5-aza-2-deoxycytidine)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (ADJP (NN time-)) (CC and) (ADJP (JJ concentration-dependent))) (NN increase)) (PP (IN of) (NP (NP (NN IRF-4) (NN mRNA)) (CC and) (NP (NN protein) (NNS levels)))))))) (. .)))
(S1 (S (ADVP (RB Second)) (, ,) (S (VP (VBG using) (NP (DT a) (ADJP (ADJP (JJ restriction-PCR-assay)) (CC and) (ADJP (JJ bisulfite-sequencing)))))) (NP (PRP we)) (VP (VBD identified) (NP (ADJP (RB specifically) (VBN methylated)) (NN CpG) (NNS sites)) (PP (PP (IN in) (NP (NN IRF-4-negative))) (CC but) (PP (RB not) (IN in) (NP (JJ IRF-4-positive) (NNS cells))))) (. .)))
(S1 (S (S (ADVP (RB Third)) (, ,) (NP (PRP we)) (ADVP (RB clearly)) (VP (VP (VBD determined) (NP (NN promoter) (NN methylation)) (PP (IN as) (NP (NP (DT a) (NN mechanism)) (PP (IN for) (NP (NP (NN IRF-4) (NN down-regulation)) (PP (IN via) (NP (NN reporter) (NN gene) (NNS assays)))))))) (, ,) (CC but) (VP (VBD did) (RB not) (VP (VB detect) (NP (NP (DT an) (NN association)) (PP (IN of) (NP (NP (NP (JJ methylational) (NN status)) (CC and) (NP (NN mRNA) (NN expression))) (PP (IN of) (NP (NP (NN DNA) (NNS methyltransferases)) (CC or) (NP (JJ methyl-CpG-binding) (NNS proteins))))))))))) (. .)))
(S1 (S (S (ADVP (RB Together)) (, ,) (NP (DT these) (NNS data)) (VP (VBP suggest) (NP (NN CpG) (JJ site-specific) (NN IRF-4) (NN promoter) (NN methylation)) (PP (IN as) (NP (NP (DT a) (JJ putative) (NN mechanism)) (PP (IN of) (NP (NP (VBN down-regulated) (NN IRF-4) (NN expression)) (PP (IN in) (NP (NN leukemia))))))))) (. .)))
